Overview

Efficacy of Oral Probiotic and Antibiotic Administration in Patients With Chronic Periodontitis

Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this randomized placebo- controlled clinical trial is to evaluate the effects of Lactobacillus rhamnosus SP1- containing probiotic tablets and azithromycin tablets as an adjunct to scaling and root planning (SRP). Material and methods: Fifty-four chronic periodontitis patients will be recruited and monitored clinically, immunologically and microbiologically at baseline, 3, 6, 9 and 12 months after therapy. All patients will receive scaling and root planning and randomly will be assigned over an probiotic experimental (SRP + probiotic, n=18), antibiotic experimental (SRP + Azithromycin, n=18) or control (SRP + placebo, n=18) group. Probiotic will be used once per day during 3 months. Antibiotic will be used once per day during 5 days.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Chile
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Azithromycin
Criteria
Inclusion Criteria:

- 14 natural teeth, excluding third molars

- 10 posterior teeth

- 35 years old

- 5 teeth with periodontal sites with probing depths ≥5mm, clinical attachment loss ≥3mm
Bleeding on probing ≥20% of sites Extensive bone loss determined radiographically

Exclusion Criteria:

- Periodontal treatment before the time of examination

- Systemic illness

- Pregnancy Anticoagulant, antibiotics and non- steroid anti- inflammatory therapy in
the 6-month period before the study